首页 > 市场调查报告书 > 医疗设备

医学影像诊断核子医学

市场调查报告书

商品编码

2001295

医用同位素市场报告：趋势、预测和竞争分析（至2035年）

Medical Isotope Market Report: Trends, Forecast and Competitive Analysis to 2035

出版日期: 2026年03月27日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录图表

全球医用同位素市场前景广阔，医院、诊断中心和研究机构预计将迎来许多机会。预计2026年至2035年，全球医用同位素市场将以3.7%的复合年增长率成长，到2035年市场规模预计将达到12.25亿美元。推动该市场成长的关键因素包括诊断影像需求的成长、标靶治疗的日益普及以及对核医领域研发投入的增加。

根据 Lucintel 的预测，放射性同位素在预测期内的成长率预计将更高，具体取决于它们的类型。
从应用领域来看，医院产业预计将呈现最高的成长率。
从区域来看，预计北美在预测期内将呈现最高的成长率。

医用同位素市场的新趋势

在技术进步、诊断和治疗应用需求不断增长以及全球为确保稳定供应所做的努力的推动下，医用同位素市场正在快速发展。随着全球医疗系统寻求更精准有效的治疗方法，市场正透过创新和策略合作进行调整以满足这些需求。新兴趋势正在塑造未来的市场结构，并影响供应链、研究重点和法律规范。这些发展不仅拓展了医用同位素的应用范围，也提高了核子医学的效率、安全性和可近性。对于希望在这个充满活力的市场中把握新机会并应对持续挑战的利害关係人相关人员，了解这些趋势至关重要。

技术创新：先进生产技术的融合，例如迴旋加速器和基于发生器的方法，正在改变同位素的生产方式。这些创新实现了现场生产，减少了对老旧核子反应炉的依赖，并提高了同位素的纯度和供应稳定性。因此，医疗机构能够获得更可靠的同位素供应，从而改善患者预后并扩大临床应用。这一趋势也加速了具有标靶诊断和治疗能力的新型同位素的研发，拓宽了核子医学的应用范围。
供应链多元化：为了降低核子反应炉停运和地缘政治议题带来的风险，各公司正在实现供应链多元化。这包括建立区域生产设施，并投资于加速器生产等替代技术。这种多元化增强了供应稳定性，减少了对少数核子反应炉的依赖，并确保了同位素的稳定供应。此外，它还促进了区域市场的发展，降低了运输成本，使全球医疗专业人员更容易获得同位素。
治疗诊断需求不断增长：治疗诊断学（Theragnostics）是治疗和诊断应用的融合，目前发展势头强劲。诸如镏-177和锕-225等医用同位素越来越多地应用于标靶癌症治疗，为患者提供个人化治疗方案。这一趋势的驱动力来自分子影像技术的进步以及对癌症生物学更深入的理解。治疗诊断的兴起正在拓展市场机会，刺激研发投入，促使监管机构制定新的核准流程，最终透过精准医疗改善患者照护。
加强监管与安全：随着市场扩张，法律规范也不断发展，以确保安全性、有效性和品管。各国政府和国际组织正在实施更严格的同位素生产、处理和处置指南。这些措施旨在最大限度地降低辐射风险，防止滥用，并确保产品品质稳定。更完善的监管提高了透明度，促进了医护人员与患者之间的信任，并推动了市场成长。各公司正在投资合规体系和安全通讯协定，以满足这些不断变化的标准。
关注永续性和环境影响：该行业日益重视环境永续实践。这包括开发更环保的生产方法、减少放射性废弃物以及提高同位素生产的能源效率。永续实践不仅能解决环境问题，也符合全球负责任医疗保健的努力。这一趋势将推动核子反应炉设计、废弃物管理和替代生产技术的创新，最终降低医用同位素供应链对环境的影响，并确保市场的长期永续发展。

总而言之，这些新趋势正从根本上重塑医用同位素市场，它们提高了供应稳定性，拓展了临床应用，并促进了永续实践。这些趋势推动了创新，提高了安全标准，并促进了全球合作，所有这些共同建立了一个更具韧性和更先进的核医学系统。

医用同位素市场近期趋势

在技术创新、诊断和治疗应用需求不断增长以及全球为确保供应稳定而做出的努力的推动下，医用同位素市场正在快速发展。这些进步正在透过实现更精准的诊断、个人化治疗和改善患者预后来变革医疗保健。随着产业的不断发展，相关人员正在大力投资研发、基础设施和永续生产方法，以满足日益增长的全球需求并应对供应链挑战。

诊断影像需求日益增长：PET 和 SPECT 扫描中医用同位素的广泛应用正在扩大诊断能力。这种增长有助于疾病的早期发现，改善治疗方案的製定，并降低医疗成本。随着人们意识的提高，越来越多的医疗机构开始采用基于同位素的诊断成像技术，这推动了市场扩张，并刺激了同位素生产和分销领域的创新。
生产技术的进步：迴旋加速器和核子反应炉技术的进步使得同位素生产更有效率且经济。这些创新减少了对老旧基础设施的依赖，提高了同位素纯度，并增强了供应可靠性。因此，市场受益于同位素供应量的提高，从而支持更广泛的医疗应用，并缓解了先前阻碍患者照护的供不应求。
永续性和供应链韧性：开发替代生产方法（例如基于加速器的系统）的努力正在解决供应链的脆弱性。这些永续的方法最大限度地减少了对数量有限的核子反应炉设施的依赖，降低了对环境的影响，并确保了同位素的稳定供应。增强供应韧性对于满足全球需求至关重要，尤其是在地缘政治紧张局势和对核子反应炉关闭的担忧加剧的情况下，有助于稳定市场。
监管与政策趋势：各国政府和国际组织正在实施相关政策，以简化核准流程，促进安全、标准化的同位素生产。这些法规加速了新型同位素和技术的市场准入，并推动了创新。强化后的法规结构也确保了安全性和质量，增强了相关人员的信心，并促进了市场成长。
新的治疗应用：医用同位素在标靶放射治疗和个人化医疗中的应用日益广泛，正在开闢新的收入来源。这些治疗方法为癌症和其他疾病提供了有效的治疗选择，并改善了患者的治疗效果。治疗应用的拓展正在推动研发投入，扩大市场规模，并确保产业的长期永续性。

这些趋势的整体影响是造就了一个更具韧性、创新性和稳健性的医用同位素市场。产能的提升、监管的支持以及应用领域的拓展正在推动市场成长，改善医疗服务，确保供应稳定，并最终造福全球患者。

The future of the global medical isotope market looks promising with opportunities in the hospital, diagnostic center, and research institute markets. The global medical isotope market is expected to reach an estimated $1,225 million by 2035 with a CAGR of 3.7% from 2026 to 2035. The major drivers for this market are the increasing demand for diagnostic imaging, the rising adoption of targeted therapies, and the growing investment in nuclear medicine advancements.

Lucintel forecasts that, within the type category, radioisotope is expected to witness higher growth over the forecast period.
Within the end use category, hospital is expected to witness the highest growth.
In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the Medical Isotope Market

The medical isotope market is experiencing rapid evolution driven by technological advancements, increasing demand for diagnostic and therapeutic applications, and global efforts to ensure supply security. As healthcare systems worldwide seek more precise and effective treatments, the market is adapting to meet these needs through innovation and strategic collaborations. Emerging trends are shaping the future landscape, influencing supply chains, research priorities, and regulatory frameworks. These developments are not only expanding the scope of medical isotope applications but also enhancing the efficiency, safety, and accessibility of nuclear medicine. Understanding these trends is crucial for stakeholders aiming to capitalize on new opportunities and address ongoing challenges in this dynamic market.

Technological Innovation: The integration of advanced production techniques such as cyclotron and generator-based methods is transforming isotope manufacturing. These innovations enable on-site production, reduce reliance on aging nuclear reactors, and improve isotope purity and availability. As a result, healthcare providers can access a more reliable supply of isotopes, leading to better patient outcomes and expanded clinical applications. This trend also fosters the development of novel isotopes with targeted diagnostic and therapeutic capabilities, broadening the scope of nuclear medicine.
Supply Chain Diversification: To mitigate risks associated with reactor shutdowns and geopolitical issues, companies are diversifying supply sources. This includes establishing regional production facilities and investing in alternative technologies like accelerator-based production. Such diversification enhances supply security, reduces dependency on limited reactor facilities, and ensures consistent availability of isotopes. It also encourages regional market growth and reduces transportation costs, making isotopes more accessible to healthcare providers worldwide.
Growing Demand for Theragnostic: The convergence of therapy and diagnostics, known as theragnostic, is gaining momentum. Medical isotopes like Lutetium-177 and Actinium-225 are increasingly used for targeted cancer treatments, offering personalized therapy options. This trend is driven by advancements in molecular imaging and a better understanding of cancer biology. The rise of theragnostic is expanding market opportunities, encouraging investment in research, and prompting regulatory bodies to develop new approval pathways, ultimately improving patient care through precision medicine.
Regulatory and Safety Enhancements: As the market expands, regulatory frameworks are evolving to ensure safety, efficacy, and quality control. Governments and international agencies are implementing stricter guidelines for isotope production, handling, and disposal. These measures aim to minimize radiation risks, prevent misuse, and ensure consistent product quality. Enhanced regulations also promote transparency and foster trust among healthcare providers and patients, facilitating market growth. Companies are investing in compliance infrastructure and safety protocols to meet these evolving standards.
Focus on Sustainability and Environmental Impact: The industry is increasingly prioritizing environmentally sustainable practices. This includes developing greener production methods, reducing radioactive waste, and improving energy efficiency in isotope manufacturing. Sustainable practices not only address environmental concerns but also align with global initiatives for responsible healthcare. This trend encourages innovation in reactor design, waste management, and alternative production technologies, ultimately reducing the environmental footprint of the medical isotope supply chain and ensuring long-term market viability.

In summary, these emerging trends are fundamentally reshaping the medical isotope market by enhancing supply security, expanding clinical applications, and promoting sustainable practices. They are driving innovation, improving safety standards, and fostering global collaboration, which collectively contribute to a more resilient and advanced nuclear medicine landscape.

Recent Developments in the Medical Isotope Market

The medical isotope market is experiencing rapid advancements driven by technological innovations, increasing demand for diagnostic and therapeutic applications, and global efforts to ensure supply stability. These developments are transforming healthcare by enabling more precise diagnostics, personalized treatments, and improved patient outcomes. As the industry evolves, stakeholders are investing heavily in research, infrastructure, and sustainable production methods to meet rising global needs and address supply chain challenges.

Growing Demand for Diagnostic Imaging: The increasing use of medical isotopes in PET and SPECT scans is expanding diagnostic capabilities. This growth enhances early disease detection, improves treatment planning, and reduces healthcare costs. As awareness rises, more healthcare facilities adopt isotope-based imaging, driving market expansion and encouraging innovation in isotope production and distribution.
Enhanced Production Technologies: Advances in cyclotron and reactor technologies are enabling more efficient, cost-effective isotope production. These innovations reduce reliance on aging infrastructure, improve isotope purity, and increase supply reliability. Consequently, the market benefits from increased availability of isotopes, supporting a broader range of medical applications and reducing shortages that previously hampered patient care.
Sustainability and Supply Chain Resilience: Efforts to develop alternative production methods, such as accelerator-based systems, are addressing supply chain vulnerabilities. These sustainable approaches minimize reliance on limited reactor facilities, lower environmental impact, and ensure consistent isotope availability. Strengthening supply resilience is critical for meeting global demand, especially amid geopolitical tensions and reactor shutdowns, thereby stabilizing the market.
Regulatory and Policy Developments: Governments and international agencies are implementing policies to streamline approval processes and promote safe, standardized isotope production. These regulations facilitate faster market entry for new isotopes and technologies, encouraging innovation. Enhanced regulatory frameworks also ensure safety and quality, boosting stakeholder confidence and fostering market growth.
Emerging Therapeutic Applications: The expanding use of medical isotopes in targeted radiotherapy and personalized medicine is opening new revenue streams. These therapies offer effective treatment options for cancer and other diseases, improving patient outcomes. The growth of therapeutic applications is driving research investments, expanding market size, and positioning the industry for long-term sustainability.

The overall impact of these developments is a more robust, innovative, and resilient medical isotope market. Enhanced production, regulatory support, and expanding applications are fostering growth, improving healthcare delivery, and ensuring supply stability, ultimately benefiting patients worldwide.

Strategic Growth Opportunities in the Medical Isotope Market

The medical isotope market is experiencing rapid growth driven by advancements in diagnostic imaging, targeted therapies, and increasing healthcare demands worldwide. Innovations in production methods and expanding applications are creating new opportunities for industry players. As the demand for precise, minimally invasive treatments rises, the market is poised for significant expansion. Strategic investments and collaborations are essential to meet the evolving needs of healthcare providers and patients, ensuring sustainable growth and technological progress in this vital sector.

Growing Demand for Diagnostic Imaging and Nuclear Medicine: The increasing prevalence of chronic diseases and cancer has driven demand for advanced diagnostic tools. Medical isotopes are essential in nuclear imaging techniques like PET and SPECT scans, providing high-resolution, real-time insights into disease states. This growth is supported by technological advancements, aging populations, and the need for early diagnosis, making medical isotopes indispensable in modern healthcare. Expanding applications and improved isotope production methods further fuel this demand.
Expansion of Targeted Radionuclide Therapy Applications: The rise of personalized medicine has boosted the use of targeted radionuclide therapies for cancer treatment. These therapies deliver radiation directly to tumor cells, minimizing damage to healthy tissue. Innovations in isotope development and conjugation techniques are enhancing treatment efficacy. Increasing clinical trials and regulatory approvals are expanding the therapeutic landscape, creating opportunities for market growth. The shift toward minimally invasive, outpatient treatments also supports this expanding application.
Innovations in Isotope Production Technologies: Advances in cyclotron and reactor technologies are improving isotope production efficiency and safety. New methods like generator systems and alternative production routes reduce reliance on aging infrastructure and geopolitical risks. These innovations enable higher yields, better purity, and cost-effective manufacturing, meeting rising global demand. Enhanced production capabilities also facilitate the development of novel isotopes for emerging diagnostic and therapeutic applications, ensuring a resilient supply chain and market growth.
Rising Investment and Collaborations in R&D: Increased funding from governments, private investors, and industry stakeholders is accelerating research and development in medical isotopes. Strategic collaborations between academia, biotech firms, and healthcare providers foster innovation and commercialization. These partnerships focus on developing new isotopes, improving existing technologies, and expanding clinical applications. R&D investments are crucial for overcoming current limitations, ensuring regulatory compliance, and bringing advanced solutions to market, thereby driving overall industry growth.
Increasing Adoption in Emerging Markets: Developing countries are recognizing the importance of medical isotopes for improving healthcare outcomes. Investments in healthcare infrastructure, rising awareness, and government initiatives are promoting adoption. These markets offer significant growth potential due to expanding healthcare access and increasing disease burden. Local production facilities and partnerships with global companies are facilitating supply chain development. The integration of medical isotopes into routine diagnostics and treatment protocols is expected to substantially boost market expansion in these regions.

The overall impact of these growth opportunities is a robust, innovative, and expanding medical isotope market. Strategic focus on technological advancements, clinical applications, and emerging markets will drive sustainable growth, improve patient outcomes, and foster global healthcare improvements. Industry stakeholders must leverage these opportunities to maintain competitiveness and meet the increasing demand for advanced medical solutions.

Medical Isotope Market Driver and Challenges

The medical isotope market is influenced by a complex interplay of technological advancements, economic factors, and regulatory frameworks. Innovations in nuclear medicine, increasing demand for diagnostic and therapeutic procedures, and global health initiatives drive growth. However, challenges such as supply chain disruptions, regulatory hurdles, and high production costs pose significant obstacles. Understanding these drivers and challenges is essential for stakeholders to navigate the evolving landscape effectively. The markets future depends on technological progress, policy support, and overcoming logistical and financial barriers, which collectively shape the trajectory of medical isotope utilization worldwide.

The factors responsible for driving the medical isotope market include:-

Technological Innovation: The development of advanced production techniques, such as cyclotron and reactor-based methods, enhances isotope availability and purity. These innovations improve diagnostic accuracy and therapeutic efficacy, expanding clinical applications. As technology evolves, costs decrease, and safety improves, fostering broader adoption. Additionally, innovations in imaging and radiotherapy equipment complement isotope use, creating a synergistic growth environment. The integration of automation and digital tracking further optimizes supply chains, ensuring timely delivery and reducing waste, which collectively accelerates market expansion.
Rising Prevalence of Chronic Diseases: The increasing incidence of cancer, cardiovascular diseases, and neurological disorders globally drives demand for diagnostic imaging and targeted therapies involving medical isotopes. As populations age and lifestyle-related health issues rise, the need for early detection and effective treatment options intensifies. This trend boosts the adoption of nuclear medicine procedures, encouraging investments in isotope production facilities and research. The expanding patient base and clinical applications directly contribute to market growth, making medical isotopes indispensable in modern healthcare.
Regulatory Support and Government Initiatives: Governments and regulatory bodies are actively promoting nuclear medicine through policies, funding, and safety standards. Initiatives to establish regional production centers and streamline approval processes facilitate market growth. Regulatory frameworks ensure safety and quality, increasing clinician and patient confidence. Supportive policies also encourage public-private partnerships and international collaborations, enhancing supply stability and innovation. These efforts create a conducive environment for market expansion, attracting investments and fostering technological advancements.
Growing Awareness and Acceptance: Increased awareness among healthcare professionals and patients about the benefits of nuclear medicine procedures boosts demand. Educational campaigns, clinical research, and positive treatment outcomes enhance acceptance. As medical communities recognize the advantages of isotope-based diagnostics and therapies, adoption rates rise. This acceptance encourages healthcare providers to invest in necessary infrastructure and training, further expanding the market. The growing acceptance also stimulates innovation and competition, leading to improved products and services.
Strategic Collaborations and Investments: Partnerships between pharmaceutical companies, research institutions, and healthcare providers accelerate isotope development and distribution. Investments in new production facilities, research projects, and supply chain infrastructure ensure market resilience. Collaborations facilitate knowledge sharing, technological transfer, and resource optimization, which are crucial for overcoming production and logistical challenges. These strategic alliances also help in navigating regulatory landscapes and expanding market reach, ultimately supporting sustainable growth.

The challenges in the medical isotope market are:

Supply Chain Disruptions: The market faces significant challenges due to reliance on aging nuclear reactors and limited production facilities. Disruptions caused by reactor shutdowns, geopolitical issues, or natural disasters can lead to shortages of critical isotopes like Technetium-99m. These shortages impact diagnostic and therapeutic procedures, causing delays and increased costs. The complex logistics involved in transporting radioactive materials further complicate supply stability. Developing alternative production methods and diversifying supply sources are essential to mitigate these risks, but such initiatives require substantial investment and regulatory approval, which can delay implementation.
High Production Costs: The production of medical isotopes involves expensive infrastructure, specialized equipment, and highly trained personnel. The costs associated with reactor operation, target material procurement, and waste management contribute to high prices, limiting accessibility, especially in low-resource settings. These costs also impact the profitability of isotope suppliers, discouraging investment in new facilities. Efforts to develop cost-effective production technologies are ongoing but face technical and regulatory hurdles. Consequently, high costs restrict widespread adoption and hinder market growth, particularly in emerging economies.
Regulatory and Safety Challenges: Stringent regulations governing the production, transportation, and disposal of radioactive materials pose significant barriers. Compliance requires substantial investment in safety measures, quality control, and personnel training. Regulatory delays can hinder the approval of new isotopes and production methods, slowing innovation. Additionally, concerns over radiation safety and waste management necessitate rigorous standards, which can increase operational costs and complexity. Navigating diverse regulatory environments across countries complicates international trade and collaboration, impacting supply stability and market expansion.

In summary, the medical isotope market is driven by technological advancements, increasing disease prevalence, supportive policies, growing awareness, and strategic collaborations. However, it faces challenges such as supply chain vulnerabilities, high production costs, and regulatory complexities. These factors collectively influence market dynamics, requiring stakeholders to innovate and adapt. Overcoming these hurdles and leveraging growth drivers will be crucial for sustainable expansion. The markets future hinges on technological progress, regulatory support, and resilient supply chains, which will determine its ability to meet the growing global demand for nuclear medicine.

List of Medical Isotope Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies medical isotope companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the medical isotope companies profiled in this report include-

Canadian Nuclear Laboratories
IBA Radiopharma Solutions
Jubilant Radiopharma
NorthStar medical radioisotopes
GE Healthcare
Isotopen Technologien Munchen
Curium

Medical Isotope Market by Segment

The study includes a forecast for the global medical isotope market by type, application, end use, and region.

Medical Isotope Market by Type [Value from 2019 to 2035]:

Stable Isotopes
Radioisotopes

Medical Isotope Market by Application [Value from 2019 to 2035]:

Diagnostic
Nuclear Therapy

Medical Isotope Market by End Use [Value from 2019 to 2035]:

Hospitals
Diagnostic Centers
Research Institutes

Medical Isotope Market by Region [Value from 2019 to 2035]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Medical Isotope Market

The medical isotope market has experienced significant shifts driven by technological advancements, regulatory changes, and geopolitical factors. Countries are investing in new production methods, diversifying supply chains, and enhancing research to meet growing healthcare demands. The global focus on nuclear medicine and personalized treatments has accelerated innovation and collaboration across nations. These developments aim to improve the availability, safety, and efficacy of medical isotopes, which are crucial for diagnostic imaging and cancer therapy. As the market evolves, understanding regional trends helps stakeholders navigate challenges and capitalize on emerging opportunities in this vital sector.

United States: The US has seen increased investment in domestic isotope production facilities, reducing reliance on imports. Regulatory agencies have streamlined approval processes for new isotopes, boosting research and clinical applications. Collaborations between government agencies and private companies have advanced the development of novel isotopes for personalized medicine. The US also focuses on expanding its supply chain resilience amid geopolitical tensions, ensuring consistent availability for hospitals and research institutions.
China: China has made substantial progress in establishing its nuclear medicine infrastructure, including new isotope production reactors. The country is investing heavily in research to develop alternative production methods, such as cyclotron technology, to reduce dependency on foreign sources. Government policies promote innovation in medical isotope applications, especially for cancer diagnosis and treatment. China aims to become a global leader in isotope manufacturing, with several new facilities coming online to meet domestic and export demands.
Germany: Germany remains a key player in the European medical isotope market, with advanced research institutions and production facilities. Recent developments include upgrades to existing reactors and the launch of new cyclotron centers to diversify supply sources. The country emphasizes sustainable and environmentally friendly production methods. Germany also collaborates closely with the European Union to ensure regulatory harmonization and secure supply chains, supporting both clinical and research needs across Europe.
India: India is rapidly expanding its medical isotope capacity, focusing on self-sufficiency to meet rising healthcare demands. New research centers and production units have been established, utilizing cyclotron technology and reactor-based methods. The government promotes public-private partnerships to accelerate innovation and infrastructure development. India is also exploring cost-effective production techniques to make isotopes more accessible for its large population, aiming to become a regional hub for nuclear medicine.
Japan: Japan has advanced its research in medical isotopes, particularly in developing novel isotopes for cancer therapy. The country has upgraded its existing reactors and invested in new cyclotron facilities to enhance production capacity. Japan emphasizes safety and environmental standards in its isotope manufacturing. It also collaborates internationally to share knowledge and improve supply chain stability, ensuring reliable access to isotopes for medical and research purposes amid global supply challenges.

Features of the Global Medical Isotope Market

Market Size Estimates: Medical isotope market size estimation in terms of value ($M).
Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
Segmentation Analysis: Medical isotope market size by type, application, end use, and region in terms of value ($M).
Regional Analysis: Medical isotope market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the medical isotope market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the medical isotope market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the medical isotope market by type (stable isotopes and radioisotopes), application (diagnostic and nuclear therapy), end use (hospitals, diagnostic centers, and research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Medical Isotope Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Stable Isotopes : Trends and Forecast (2019-2035)
4.4 Radioisotopes : Trends and Forecast (2019-2035)

5. Global Medical Isotope Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Diagnostic : Trends and Forecast (2019-2035)
5.4 Nuclear Therapy : Trends and Forecast (2019-2035)

6. Global Medical Isotope Market by End Use

6.1 Overview
6.2 Attractiveness Analysis by End Use
6.3 Hospitals : Trends and Forecast (2019-2035)
6.4 Diagnostic Centers : Trends and Forecast (2019-2035)
6.5 Research Institutes : Trends and Forecast (2019-2035)

7. Regional Analysis

7.1 Overview
7.2 Global Medical Isotope Market by Region

8. North American Medical Isotope Market

8.1 Overview
8.2 North American Medical Isotope Market by Type
8.3 North American Medical Isotope Market by End Use
8.4 The United States Medical Isotope Market
8.5 Canadian Medical Isotope Market
8.6 Mexican Medical Isotope Market

9. European Medical Isotope Market

9.1 Overview
9.2 European Medical Isotope Market by Type
9.3 European Medical Isotope Market by End Use
9.4 German Medical Isotope Market
9.5 French Medical Isotope Market
9.6 Italian Medical Isotope Market
9.7 Spanish Medical Isotope Market
9.8 The United Kingdom Medical Isotope Market

10. APAC Medical Isotope Market

10.1 Overview
10.2 APAC Medical Isotope Market by Type
10.3 APAC Medical Isotope Market by End Use
10.4 Chinese Medical Isotope Market
10.5 Indian Medical Isotope Market
10.6 Japanese Medical Isotope Market
10.7 South Korean Medical Isotope Market
10.8 Indonesian Medical Isotope Market

11. ROW Medical Isotope Market

11.1 Overview
11.2 ROW Medical Isotope Market by Type
11.3 ROW Medical Isotope Market by End Use
11.4 Middle Eastern Medical Isotope Market
11.5 South American Medical Isotope Market
11.6 African Medical Isotope Market

12. Competitor Analysis

12.1 Product Portfolio Analysis
12.2 Operational Integration
12.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
12.4 Market Share Analysis

13. Opportunities & Strategic Analysis

13.1 Value Chain Analysis
13.2 Growth Opportunity Analysis
- 13.2.1 Growth Opportunity by Type
- 13.2.2 Growth Opportunity by Application
- 13.2.3 Growth Opportunity by End Use
13.3 Emerging Trends in the Global Medical Isotope Market
13.4 Strategic Analysis
- 13.4.1 New Product Development
- 13.4.2 Certification and Licensing
- 13.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

14. Company Profiles of the Leading Players Across the Value Chain

14.1 Competitive Analysis Overview
14.2 Canadian Nuclear Laboratories
- Company Overview
- Medical Isotope Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.3 IBA Radiopharma Solutions
- Company Overview
- Medical Isotope Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.4 Jubilant Radiopharma
- Company Overview
- Medical Isotope Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.5 NorthStar medical radioisotopes
- Company Overview
- Medical Isotope Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.6 GE Healthcare
- Company Overview
- Medical Isotope Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.7 Isotopen Technologien Munchen
- Company Overview
- Medical Isotope Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.8 Curium
- Company Overview
- Medical Isotope Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

15. Appendix

15.1 List of Figures
15.2 List of Tables
15.3 Research Methodology
15.4 Disclaimer
15.5 Copyright
15.6 Abbreviations and Technical Units
15.7 About Us
15.8 Contact Us

简介目录图表

List of Figures

Figure 1.1: Trends and Forecast for the Global Medical Isotope Market
Figure 2.1: Usage of Medical Isotope Market
Figure 2.2: Classification of the Global Medical Isotope Market
Figure 2.3: Supply Chain of the Global Medical Isotope Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 3.19: Driver and Challenges of the Medical Isotope Market
Figure 4.1: Global Medical Isotope Market by Type in 2019, 2025, and 2035
Figure 4.2: Trends of the Global Medical Isotope Market ($B) by Type
Figure 4.3: Forecast for the Global Medical Isotope Market ($B) by Type
Figure 4.4: Trends and Forecast for Stable Isotopes in the Global Medical Isotope Market (2019-2035)
Figure 4.5: Trends and Forecast for Radioisotopes in the Global Medical Isotope Market (2019-2035)
Figure 5.1: Global Medical Isotope Market by Application in 2019, 2025, and 2035
Figure 5.2: Trends of the Global Medical Isotope Market ($B) by Application
Figure 5.3: Forecast for the Global Medical Isotope Market ($B) by Application
Figure 5.4: Trends and Forecast for Diagnostic in the Global Medical Isotope Market (2019-2035)
Figure 5.5: Trends and Forecast for Nuclear Therapy in the Global Medical Isotope Market (2019-2035)
Figure 6.1: Global Medical Isotope Market by End Use in 2019, 2025, and 2035
Figure 6.2: Trends of the Global Medical Isotope Market ($B) by End Use
Figure 6.3: Forecast for the Global Medical Isotope Market ($B) by End Use
Figure 6.4: Trends and Forecast for Hospitals in the Global Medical Isotope Market (2019-2035)
Figure 6.5: Trends and Forecast for Diagnostic Centers in the Global Medical Isotope Market (2019-2035)
Figure 6.6: Trends and Forecast for Research Institutes in the Global Medical Isotope Market (2019-2035)
Figure 7.1: Trends of the Global Medical Isotope Market ($B) by Region (2019-2025)
Figure 7.2: Forecast for the Global Medical Isotope Market ($B) by Region (2026-2035)
Figure 8.1: Trends and Forecast for the North American Medical Isotope Market (2019-2035)
Figure 8.2: North American Medical Isotope Market by Type in 2019, 2025, and 2035
Figure 8.3: Trends of the North American Medical Isotope Market ($B) by Type (2019-2025)
Figure 8.4: Forecast for the North American Medical Isotope Market ($B) by Type (2026-2035)
Figure 8.5: North American Medical Isotope Market by Application in 2019, 2025, and 2035
Figure 8.6: Trends of the North American Medical Isotope Market ($B) by Application (2019-2025)
Figure 8.7: Forecast for the North American Medical Isotope Market ($B) by Application (2026-2035)
Figure 8.8: North American Medical Isotope Market by End Use in 2019, 2025, and 2035
Figure 8.9: Trends of the North American Medical Isotope Market ($B) by End Use (2019-2025)
Figure 8.10: Forecast for the North American Medical Isotope Market ($B) by End Use (2026-2035)
Figure 8.11: Trends and Forecast for the United States Medical Isotope Market ($B) (2019-2035)
Figure 8.12: Trends and Forecast for the Mexican Medical Isotope Market ($B) (2019-2035)
Figure 8.13: Trends and Forecast for the Canadian Medical Isotope Market ($B) (2019-2035)
Figure 9.1: Trends and Forecast for the European Medical Isotope Market (2019-2035)
Figure 9.2: European Medical Isotope Market by Type in 2019, 2025, and 2035
Figure 9.3: Trends of the European Medical Isotope Market ($B) by Type (2019-2025)
Figure 9.4: Forecast for the European Medical Isotope Market ($B) by Type (2026-2035)
Figure 9.5: European Medical Isotope Market by Application in 2019, 2025, and 2035
Figure 9.6: Trends of the European Medical Isotope Market ($B) by Application (2019-2025)
Figure 9.7: Forecast for the European Medical Isotope Market ($B) by Application (2026-2035)
Figure 9.8: European Medical Isotope Market by End Use in 2019, 2025, and 2035
Figure 9.9: Trends of the European Medical Isotope Market ($B) by End Use (2019-2025)
Figure 9.10: Forecast for the European Medical Isotope Market ($B) by End Use (2026-2035)
Figure 9.11: Trends and Forecast for the German Medical Isotope Market ($B) (2019-2035)
Figure 9.12: Trends and Forecast for the French Medical Isotope Market ($B) (2019-2035)
Figure 9.13: Trends and Forecast for the Spanish Medical Isotope Market ($B) (2019-2035)
Figure 9.14: Trends and Forecast for the Italian Medical Isotope Market ($B) (2019-2035)
Figure 9.15: Trends and Forecast for the United Kingdom Medical Isotope Market ($B) (2019-2035)
Figure 10.1: Trends and Forecast for the APAC Medical Isotope Market (2019-2035)
Figure 10.2: APAC Medical Isotope Market by Type in 2019, 2025, and 2035
Figure 10.3: Trends of the APAC Medical Isotope Market ($B) by Type (2019-2025)
Figure 10.4: Forecast for the APAC Medical Isotope Market ($B) by Type (2026-2035)
Figure 10.5: APAC Medical Isotope Market by Application in 2019, 2025, and 2035
Figure 10.6: Trends of the APAC Medical Isotope Market ($B) by Application (2019-2025)
Figure 10.7: Forecast for the APAC Medical Isotope Market ($B) by Application (2026-2035)
Figure 10.8: APAC Medical Isotope Market by End Use in 2019, 2025, and 2035
Figure 10.9: Trends of the APAC Medical Isotope Market ($B) by End Use (2019-2025)
Figure 10.10: Forecast for the APAC Medical Isotope Market ($B) by End Use (2026-2035)
Figure 10.11: Trends and Forecast for the Japanese Medical Isotope Market ($B) (2019-2035)
Figure 10.12: Trends and Forecast for the Indian Medical Isotope Market ($B) (2019-2035)
Figure 10.13: Trends and Forecast for the Chinese Medical Isotope Market ($B) (2019-2035)
Figure 10.14: Trends and Forecast for the South Korean Medical Isotope Market ($B) (2019-2035)
Figure 10.15: Trends and Forecast for the Indonesian Medical Isotope Market ($B) (2019-2035)
Figure 11.1: Trends and Forecast for the ROW Medical Isotope Market (2019-2035)
Figure 11.2: ROW Medical Isotope Market by Type in 2019, 2025, and 2035
Figure 11.3: Trends of the ROW Medical Isotope Market ($B) by Type (2019-2025)
Figure 11.4: Forecast for the ROW Medical Isotope Market ($B) by Type (2026-2035)
Figure 11.5: ROW Medical Isotope Market by Application in 2019, 2025, and 2035
Figure 11.6: Trends of the ROW Medical Isotope Market ($B) by Application (2019-2025)
Figure 11.7: Forecast for the ROW Medical Isotope Market ($B) by Application (2026-2035)
Figure 11.8: ROW Medical Isotope Market by End Use in 2019, 2025, and 2035
Figure 11.9: Trends of the ROW Medical Isotope Market ($B) by End Use (2019-2025)
Figure 11.10: Forecast for the ROW Medical Isotope Market ($B) by End Use (2026-2035)
Figure 11.11: Trends and Forecast for the Middle Eastern Medical Isotope Market ($B) (2019-2035)
Figure 11.12: Trends and Forecast for the South American Medical Isotope Market ($B) (2019-2035)
Figure 11.13: Trends and Forecast for the African Medical Isotope Market ($B) (2019-2035)
Figure 12.1: Porter's Five Forces Analysis of the Global Medical Isotope Market
Figure 12.2: Market Share (%) of Top Players in the Global Medical Isotope Market (2025)
Figure 13.1: Growth Opportunities for the Global Medical Isotope Market by Type
Figure 13.2: Growth Opportunities for the Global Medical Isotope Market by Application
Figure 13.3: Growth Opportunities for the Global Medical Isotope Market by End Use
Figure 13.4: Growth Opportunities for the Global Medical Isotope Market by Region
Figure 13.5: Emerging Trends in the Global Medical Isotope Market

List of Tables

Table 1.1: Growth Rate (%, 2024-2025) and CAGR (%, 2026-2035) of the Medical Isotope Market by Type, Application, and End Use
Table 1.2: Attractiveness Analysis for the Medical Isotope Market by Region
Table 1.3: Global Medical Isotope Market Parameters and Attributes
Table 3.1: Trends of the Global Medical Isotope Market (2019-2025)
Table 3.2: Forecast for the Global Medical Isotope Market (2026-2035)
Table 4.1: Attractiveness Analysis for the Global Medical Isotope Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Medical Isotope Market (2019-2025)
Table 4.3: Market Size and CAGR of Various Type in the Global Medical Isotope Market (2026-2035)
Table 4.4: Trends of Stable Isotopes in the Global Medical Isotope Market (2019-2025)
Table 4.5: Forecast for Stable Isotopes in the Global Medical Isotope Market (2026-2035)
Table 4.6: Trends of Radioisotopes in the Global Medical Isotope Market (2019-2025)
Table 4.7: Forecast for Radioisotopes in the Global Medical Isotope Market (2026-2035)
Table 5.1: Attractiveness Analysis for the Global Medical Isotope Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Medical Isotope Market (2019-2025)
Table 5.3: Market Size and CAGR of Various Application in the Global Medical Isotope Market (2026-2035)
Table 5.4: Trends of Diagnostic in the Global Medical Isotope Market (2019-2025)
Table 5.5: Forecast for Diagnostic in the Global Medical Isotope Market (2026-2035)
Table 5.6: Trends of Nuclear Therapy in the Global Medical Isotope Market (2019-2025)
Table 5.7: Forecast for Nuclear Therapy in the Global Medical Isotope Market (2026-2035)
Table 6.1: Attractiveness Analysis for the Global Medical Isotope Market by End Use
Table 6.2: Market Size and CAGR of Various End Use in the Global Medical Isotope Market (2019-2025)
Table 6.3: Market Size and CAGR of Various End Use in the Global Medical Isotope Market (2026-2035)
Table 6.4: Trends of Hospitals in the Global Medical Isotope Market (2019-2025)
Table 6.5: Forecast for Hospitals in the Global Medical Isotope Market (2026-2035)
Table 6.6: Trends of Diagnostic Centers in the Global Medical Isotope Market (2019-2025)
Table 6.7: Forecast for Diagnostic Centers in the Global Medical Isotope Market (2026-2035)
Table 6.8: Trends of Research Institutes in the Global Medical Isotope Market (2019-2025)
Table 6.9: Forecast for Research Institutes in the Global Medical Isotope Market (2026-2035)
Table 7.1: Market Size and CAGR of Various Regions in the Global Medical Isotope Market (2019-2025)
Table 7.2: Market Size and CAGR of Various Regions in the Global Medical Isotope Market (2026-2035)
Table 8.1: Trends of the North American Medical Isotope Market (2019-2025)
Table 8.2: Forecast for the North American Medical Isotope Market (2026-2035)
Table 8.3: Market Size and CAGR of Various Type in the North American Medical Isotope Market (2019-2025)
Table 8.4: Market Size and CAGR of Various Type in the North American Medical Isotope Market (2026-2035)
Table 8.5: Market Size and CAGR of Various Application in the North American Medical Isotope Market (2019-2025)
Table 8.6: Market Size and CAGR of Various Application in the North American Medical Isotope Market (2026-2035)
Table 8.7: Market Size and CAGR of Various End Use in the North American Medical Isotope Market (2019-2025)
Table 8.8: Market Size and CAGR of Various End Use in the North American Medical Isotope Market (2026-2035)
Table 8.9: Trends and Forecast for the United States Medical Isotope Market (2019-2035)
Table 8.10: Trends and Forecast for the Mexican Medical Isotope Market (2019-2035)
Table 8.11: Trends and Forecast for the Canadian Medical Isotope Market (2019-2035)
Table 9.1: Trends of the European Medical Isotope Market (2019-2025)
Table 9.2: Forecast for the European Medical Isotope Market (2026-2035)
Table 9.3: Market Size and CAGR of Various Type in the European Medical Isotope Market (2019-2025)
Table 9.4: Market Size and CAGR of Various Type in the European Medical Isotope Market (2026-2035)
Table 9.5: Market Size and CAGR of Various Application in the European Medical Isotope Market (2019-2025)
Table 9.6: Market Size and CAGR of Various Application in the European Medical Isotope Market (2026-2035)
Table 9.7: Market Size and CAGR of Various End Use in the European Medical Isotope Market (2019-2025)
Table 9.8: Market Size and CAGR of Various End Use in the European Medical Isotope Market (2026-2035)
Table 9.9: Trends and Forecast for the German Medical Isotope Market (2019-2035)
Table 9.10: Trends and Forecast for the French Medical Isotope Market (2019-2035)
Table 9.11: Trends and Forecast for the Spanish Medical Isotope Market (2019-2035)
Table 9.12: Trends and Forecast for the Italian Medical Isotope Market (2019-2035)
Table 9.13: Trends and Forecast for the United Kingdom Medical Isotope Market (2019-2035)
Table 10.1: Trends of the APAC Medical Isotope Market (2019-2025)
Table 10.2: Forecast for the APAC Medical Isotope Market (2026-2035)
Table 10.3: Market Size and CAGR of Various Type in the APAC Medical Isotope Market (2019-2025)
Table 10.4: Market Size and CAGR of Various Type in the APAC Medical Isotope Market (2026-2035)
Table 10.5: Market Size and CAGR of Various Application in the APAC Medical Isotope Market (2019-2025)
Table 10.6: Market Size and CAGR of Various Application in the APAC Medical Isotope Market (2026-2035)
Table 10.7: Market Size and CAGR of Various End Use in the APAC Medical Isotope Market (2019-2025)
Table 10.8: Market Size and CAGR of Various End Use in the APAC Medical Isotope Market (2026-2035)
Table 10.9: Trends and Forecast for the Japanese Medical Isotope Market (2019-2035)
Table 10.10: Trends and Forecast for the Indian Medical Isotope Market (2019-2035)
Table 10.11: Trends and Forecast for the Chinese Medical Isotope Market (2019-2035)
Table 10.12: Trends and Forecast for the South Korean Medical Isotope Market (2019-2035)
Table 10.13: Trends and Forecast for the Indonesian Medical Isotope Market (2019-2035)
Table 11.1: Trends of the ROW Medical Isotope Market (2019-2025)
Table 11.2: Forecast for the ROW Medical Isotope Market (2026-2035)
Table 11.3: Market Size and CAGR of Various Type in the ROW Medical Isotope Market (2019-2025)
Table 11.4: Market Size and CAGR of Various Type in the ROW Medical Isotope Market (2026-2035)
Table 11.5: Market Size and CAGR of Various Application in the ROW Medical Isotope Market (2019-2025)
Table 11.6: Market Size and CAGR of Various Application in the ROW Medical Isotope Market (2026-2035)
Table 11.7: Market Size and CAGR of Various End Use in the ROW Medical Isotope Market (2019-2025)
Table 11.8: Market Size and CAGR of Various End Use in the ROW Medical Isotope Market (2026-2035)
Table 11.9: Trends and Forecast for the Middle Eastern Medical Isotope Market (2019-2035)
Table 11.10: Trends and Forecast for the South American Medical Isotope Market (2019-2035)
Table 11.11: Trends and Forecast for the African Medical Isotope Market (2019-2035)
Table 12.1: Product Mapping of Medical Isotope Suppliers Based on Segments
Table 12.2: Operational Integration of Medical Isotope Manufacturers
Table 12.3: Rankings of Suppliers Based on Medical Isotope Revenue
Table 13.1: New Product Launches by Major Medical Isotope Producers (2019-2025)
Table 13.2: Certification Acquired by Major Competitor in the Global Medical Isotope Market

02-2729-4219

+886-2-2729-4219

License/价格

医用同位素市场报告：趋势、预测和竞争分析（至2035年）

Medical Isotope Market Report: Trends, Forecast and Competitive Analysis to 2035

目录

第一章执行摘要

第二章 市场概览

第三章 市场趋势与预测分析

第四章 全球医用同位素市场：按类型划分

第五章 全球医用同位素市场：依应用领域划分

第六章 全球医用同位素市场：依最终用途划分

第七章 区域分析

第八章：北美医用同位素市场

第九章：欧洲医用同位素市场

第十章：亚太地区医用同位素市场

第十一章：世界其他地区的医用同位素市场

第十二章 竞争分析

第十三章 机会与策略分析

第十四章：价值链中主要企业的公司概况

第十五章附录